These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7424174)

  • 1. [International efforts in the field of drug safety].
    Bertaux JF
    Soz Praventivmed; 1980 Mar; 25(1-2):23-5. PubMed ID: 7424174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing surveillance of adverse reactions to new medicines.
    Wilson AB
    Br Med J; 1977 Oct; 2(6093):1001-3. PubMed ID: 922357
    [No Abstract]   [Full Text] [Related]  

  • 3. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Questions on the monitoring of drug consumption at the 7th International pharmaceutical Congress held in Paris, July 16-21, 1978].
    Stika L
    Cesk Zdrav; 1979 Jul; 27(7):320-4. PubMed ID: 36993
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.
    Olsson S
    Drug Saf; 1998 Jul; 19(1):1-10. PubMed ID: 9673854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International regulatory aspects of clinical periodontal research.
    Cooley WE; Castellion AW
    Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug evaluation: new requirements and perspectives].
    Addis A; Rocchi F
    Recenti Prog Med; 2006 Nov; 97(11):618-25. PubMed ID: 17252718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of drug safety.
    Breckenridge A
    Clin Pharmacol Ther; 2007 Feb; 81(2):161-3. PubMed ID: 17259942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of Vigimed, a global e-mail system for the exchange of pharmacovigilance information.
    Johansson K; Olsson S; Hellman B; Meyboom RH
    Drug Saf; 2007; 30(10):883-9. PubMed ID: 17867725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Making Patient-focused Information Provision a Reality: One Company's Approach].
    Takemoto S
    Yakugaku Zasshi; 2018; 138(3):315-323. PubMed ID: 29503422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology for international drug monitoring.
    Royal BW; Venulet J
    Methods Inf Med; 1972 Apr; 11(2):75-86. PubMed ID: 5026576
    [No Abstract]   [Full Text] [Related]  

  • 12. The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?
    Edwards IR
    Drug Saf; 2005; 28(5):379-86. PubMed ID: 15853440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Law, medicines and the doctor: a critical look at drug regulation.
    Dukes MN
    Curr Med Res Opin; 1973; 1(10):612-28. PubMed ID: 4778727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug safety: activities of the manufacturer].
    Krupp P
    Soz Praventivmed; 1980 Mar; 25(1-2):14-7. PubMed ID: 7424173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacovigilance and communicating safety information.
    Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 2002; 902():i-vii, 1-208. PubMed ID: 12082969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis.
    Onakpoya IJ; Heneghan CJ; Aronson JK
    BMC Med; 2015 Feb; 13():26. PubMed ID: 25651859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to improve drug development and utilization in pediatrics].
    Pons G; Lassale C; Eschwege E
    Therapie; 1999; 54(4):423-32. PubMed ID: 10667109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global pharmaceutical regulation: the challenge of integration for developing states.
    Pezzola A; Sweet CM
    Global Health; 2016 Dec; 12(1):85. PubMed ID: 27998293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.